Skip to main content

Table 2 Impact of Different Treatment Models on Survival

From: Postoperative radiotherapy is effective in improving survival of patients with stage pIII-N2 non-small-cell lung Cancer after pneumonectomy

 

Total (n = 119)

R0 resection (n = 104)

non-R0 resection (n = 15)

PORT

Control

p-value

PORT

Control

p-value

PORT

Control

p-value

Case number

32

87

/

24

80

/

8

7

/

MST (mos)

NR

34

0.003

NR

34

0.032

NR

24

0.021

mDFS (mos)

19

13

0.024

18

13

0.111

33

9

0.048

mLRFS (mos)

95

22

0.012

95

22

0.033

33

9

0.045

mDMFS (mos)

47

17

0.047

19

18

0.179

112

11

0.087

  1. Abbreviation: PORT postoperative radiotherapy, MST median survival time, mDFS median disease free survival, mLRFS median local recurrence free survival, mDMFS median distant metastasis free survival, mos months